Skip to main content

Articles

1215 result(s) for 'cancer' within Journal of Ovarian Research

Page 14 of 25

  1. Chemotherapy resistance presents a difficult challenge in treating epithelial ovarian cancer patients, particularly when tumors exhibit resistance to ... shown that elevated serum levels of the ovarian cancer bio...

    Authors: J. R. Ribeiro, C. Schorl, N. Yano, N. Romano, K. K. Kim, R. K. Singh and R. G. Moore
    Citation: Journal of Ovarian Research 2016 9:28
  2. Exosomes are nanoparticles(40-100 nm) secreted by most cells in the body, which can be isolated from several types of extracellular fluids. It has been shown that exosomes play a key role in intercellular communi...

    Authors: Lin Cheng, Shuying Wu, Kun Zhang, Yun’an Qing and Tianmin Xu
    Citation: Journal of Ovarian Research 2017 10:73
  3. Ageing, socioeconomic level, obesity, fertility, relaxed natural selection and urbanization have been postulated as the risk factors of ovarian cancer (OC56). We sought to identify which...

    Authors: Wenpeng You, Ian Symonds and Maciej Henneberg
    Citation: Journal of Ovarian Research 2018 11:68
  4. Ovarian cancer (OC) is the most lethal gynecological ... underlying causes will help further research on effective cancer management among diverse patient population and ultimately...

    Authors: Sanjeev K. Srivastava, Aamir Ahmad, Orlandric Miree, Girijesh Kumar Patel, Seema Singh, Rodney P. Rocconi and Ajay P. Singh
    Citation: Journal of Ovarian Research 2017 10:58
  5. Recent studies have shown diagnostic and prognostic values of circulating tumor cells (CTCs) and disseminated tumor cells (DTCs) in various cancers, including ovarian cancer. We aimed to evaluate the association ...

    Authors: Long Cui, Joseph Kwong and Chi Chiu Wang
    Citation: Journal of Ovarian Research 2015 8:38
  6. Ovarian cancer has emerged as one of the leading ... blood and transvaginal ultrasound examination are essential ovarian cancer diagnostic methods. However, their sensitivity and ... Because of a high mortality r...

    Authors: Agata Swiatly, Szymon Plewa, Jan Matysiak and Zenon J. Kokot
    Citation: Journal of Ovarian Research 2018 11:88
  7. Ovarian cancer is the 5th leading cause of death for women with cancer worldwide. In more than 70% of ... update on the biological markers for diagnosing ovarian cancer, specifically HE4, CA 125, RMI and...

    Authors: Vincent Dochez, Hélène Caillon, Edouard Vaucel, Jérôme Dimet, Norbert Winer and Guillaume Ducarme
    Citation: Journal of Ovarian Research 2019 12:28
  8. Ovarian cancer early detection markers CA125, CA15.3,...

    Authors: Renée T. Fortner, Allison F. Vitonis, Helena Schock, Anika Hüsing, Theron Johnson, Raina N. Fichorova, Titilayo Fashemi, Hidemi S. Yamamoto, Anne Tjønneland, Louise Hansen, Kim Overvad, Marie-Christine Boutron-Ruault, Marina Kvaskoff, Gianluca Severi, Heiner Boeing, Antonia Trichopoulou…
    Citation: Journal of Ovarian Research 2017 10:20
  9. Cisplatin-based chemotherapy is the first-line treatment for ovarian cancer. However, acquired resistance to cisplatin treatment often occurs in epithelial ovarian cancer, and effective and practical methods for ...

    Authors: Bo Zhou, Meng Xia, Bin Wang, Niresh Thapa, Lijuan Gan, Chaoyang Sun, Ensong Guo, Jia Huang, Yulan Lu and Hongbin Cai
    Citation: Journal of Ovarian Research 2019 12:107
  10. Mitochondrial dynamics (e.g. fission/fusion) play an important role in controlling chemoresistance in representative gynecologic malignancies, ovarian and cervical cancer. Processing the long form of Optic atroph...

    Authors: Bao Kong, Chae Young Han, Se Ik Kim, David A. Patten, Youngjin Han, Euridice Carmona, Dar-Bin Shieh, Annie C. Cheung, Anne-Marie Mes-Masson, Mary-Ellen Harper, Yong Sang Song and Benjamin K. Tsang
    Citation: Journal of Ovarian Research 2022 15:70
  11. Pelvic irradiation is essential for improving survival in women with pelvic malignancies despite inducing permanent ovarian damage. Ovarian transposition can be performed in premenopausal women in an attempt t...

    Authors: Kumar Gubbala, Alex Laios, Ioannis Gallos, Pubudu Pathiraja, Krishnayan Haldar and Thomas Ind
    Citation: Journal of Ovarian Research 2014 7:69
  12. Ovarian clear cell carcinoma (OCCC) is a rare pathological histotype in ovarian cancer, while the survival rate of advanced OCCC ... lower than that of the advanced serous ovarian cancer (OSC), which is the most ...

    Authors: Tingwei Liu, Yueqing Gao, Shuangdi Li and Shaohua Xu
    Citation: Journal of Ovarian Research 2024 17:119
  13. Amplified centrosomes in cancers are recently garnering a lot of attention ... indispensable for the viability of extra centrosome-bearing cancer cells, and may underlie progression of ovarian cancers.

    Authors: Shrikant Pawar, Shashikiran Donthamsetty, Vaishali Pannu, Padmashree Rida, Angela Ogden, Nathan Bowen, Remus Osan, Guilherme Cantuaria and Ritu Aneja
    Citation: Journal of Ovarian Research 2014 7:53
  14. Ovarian carcinoma is the leading cause of cancer death worldwide among gynecological malignancies, and the ... cases are related with recurrence and chemoresistance. Cancer stem cells (CSCs) are believed to ... o...

    Authors: Young Tae Park, Ju-yeon Jeong, Mi-jung Lee, Kwang-il Kim, Tae-Heon Kim, Young-do Kwon, Chan Lee, Ok Jun Kim and Hee-Jung An
    Citation: Journal of Ovarian Research 2013 6:18
  15. Of 211 patients, 73 had pure EC, and 91 had pure CCC, and the remaining 47 had mixed cancer. The proportion of EC and CCC remained...p = 0.001).

    Authors: Ling Zhou, Liqing Yao, Lin Dai, Honglan Zhu, Xue Ye, Shang Wang, Hongyan Cheng, Ruiqiong Ma, Huiping Liu, Heng Cui and Xiaohong Chang
    Citation: Journal of Ovarian Research 2021 14:63
  16. Ovarian cancer is the first leading cause of death in gynecological cancers. The continuous survival and metastasis of cancer cells are the main causes of death and poor prognosis in patients with ovarian cancer....

    Authors: Jie Li, Songlin Zhang, Lei Wu, Meili Pei and Yu Jiang
    Citation: Journal of Ovarian Research 2021 14:4
  17. MicroRNAs (miRNAs) play crucial functions in the progression of ovarian cancer. MicroRNA-27b-5p (miR-27b-5p) has been identified as a cancer-associated miRNA. Nevertheless, the expression profile ... miR-27b-5p a...

    Authors: Chun Hua Liu, Xue Ning Jing, Xiao Lan Liu, Shan Yong Qin, Min Wei Liu and Chun Hong Hou
    Citation: Journal of Ovarian Research 2020 13:92
  18. The expression of leukocyte antigen-E (HLA-E), IFN-γ, CD3 and CD56 in clinical samples of ovarian cancer was detected by mutiplexed immunohistochemistry. The mechanism ... by IFN-γ was explored using human ovaria...

    Authors: Hui Zheng, Xiaolin Guan, Xin Meng, Ying Tong, Yanchun Wang, Suhong Xie, Lin Guo and Renquan Lu
    Citation: Journal of Ovarian Research 2023 16:229
  19. The mean age was 48 years (range, 18–83). Approximately 60% of patients were premenopausal women. The two most common nongynecologic primary sites of ovarian metastasis were the colorectum (68 cases) and stomach ...

    Authors: Jing-Jing Zhang, Dong-Yan Cao, Jia-Xin Yang and Keng Shen
    Citation: Journal of Ovarian Research 2020 13:128
  20. VEGF may play a role in the pathogenesis of cancer disease, for example in cell growth, ... and the established tumor marker CA125 in ovarian cancer patients (100) as compared to control...

    Authors: Sławomir Ławicki, Grażyna Ewa Będkowska, Ewa Gacuta-Szumarska and Maciej Szmitkowski
    Citation: Journal of Ovarian Research 2013 6:45
  21. Ovarian cancer is the most lethal gynecologic disease due...

    Authors: Olga Lilia Garibay-Cerdenares, Verónica Ivonne Hernández-Ramírez, Juan Carlos Osorio-Trujillo, Magdalena Hernández-Ortíz, Dolores Gallardo-Rincón, David Cantú de León, Sergio Encarnación-Guevara, Julio César Villegas-Pineda and Patricia Talamás-Rohana
    Citation: Journal of Ovarian Research 2014 7:27
  22. Activation of bone morphogenetic protein (BMP)4 signalling in human ovarian cancer cells induces a number of phenotypic changes in vitro, including altered cell morphology, adhesion, motility and invasion, relati...

    Authors: Trevor G Shepherd, Michelle L Mujoomdar and Mark W Nachtigal
    Citation: Journal of Ovarian Research 2010 3:5
  23. Ovarian cancer is the most common gynecological malignancy that causes cancer-related deaths in women today; this being ... the case, developing an understanding of ovarian cancer has become one of the major driv...

    Authors: Yingyu Dou, Xiaoyan Jiang, Hui Xie, Junyu He and Songshu Xiao
    Citation: Journal of Ovarian Research 2019 12:99
  24. Low-grade ovarian cancers represent up to 8% of all epithelial ... EOCs. EMT plays a key role in cancer invasion, metastasis formation and chemotherapy resistance....

    Authors: Paweł Sadłecki, Marek Grabiec, Dariusz Grzanka, Jakub Jóźwicki, Paulina Antosik and Małgorzata Walentowicz-Sadłecka
    Citation: Journal of Ovarian Research 2019 12:23
  25. RNA interference technology has shown high therapeutic potential for cancer treatment. However, serum instability, poor tissue...in vivo.... To overcome these limitations and improve the specificity for ovarian cancer

    Authors: Shanshan Hong, Xiaoyan Zhang, Jun Chen, Jiabing Zhou, Yufang Zheng and Congjian Xu
    Citation: Journal of Ovarian Research 2013 6:80
  26. Ovarian cancer is the most lethal gynecologic malignancy. The ... overexpressed in many solid neoplasms, including ovarian cancers, and contributes to neoplastic transformation and drug...

    Authors: Nicole S Anderson, Leslie Turner, Sandra Livingston, Ren Chen, Santo V Nicosia and Patricia A Kruk
    Citation: Journal of Ovarian Research 2009 2:16
  27. Central nervous system (CNS) spreading from epithelial ovarian carcinoma (EOC) is an uncommon but increasing phenomenon. We previously reported in a small series of 11 patients a correlation between Androgen R...

    Authors: Gloria Mittica, Margherita Goia, Angela Gambino, Giulia Scotto, Mattia Fonte, Rebecca Senetta, Massimo Aglietta, Fulvio Borella, Anna Sapino, Dionyssios Katsaros, Furio Maggiorotto, Eleonora Ghisoni, Gaia Giannone, Valentina Tuninetti, Sofia Genta, Chiara Eusebi…
    Citation: Journal of Ovarian Research 2020 13:53
  28. Ovarian cancer is the most fatal gynecologic malignancy in ... is effective in the vast majority of ovarian cancer patients, recurrence and resistance to standard systemic ... that treating high grade, platinum r...

    Authors: Katie K. Crean-Tate, Chad Braley, Goutam Dey, Emily Esakov, Caner Saygin, Alexandria Trestan, Daniel J. Silver, Soumya M. Turaga, Elizabeth V. Connor, Robert DeBernardo, Chad M. Michener, Peter G. Rose, Justin Lathia and Ofer Reizes
    Citation: Journal of Ovarian Research 2021 14:55
  29. As we have previously reported, small cell carcinoma of the ovary (SCCO) is a rare, aggressive form of ovarian cancer associated with poor outcomes. In an effort...

    Authors: George Yaghmour, Philippe Prouet, Eric Wiedower, Omer Hassan Jamy, Rebecca Feldman, Jason C Chandler, Manjari Pandey and Mike G Martin
    Citation: Journal of Ovarian Research 2016 9:52
  30. Relapsed epithelial ovarian cancer (EOC) is frequently treated with pegylated...

    Authors: Eleonora Ghisoni, Furio Maggiorotto, Fulvio Borella, Gloria Mittica, Sofia Genta, Gaia Giannone, Dionyssios Katsaros, Alberto Sciarrillo, Annamaria Ferrero, Ivana Sarotto, Jessica Erriquez, Maria Flavia Di Renzo, Massimo Aglietta and Giorgio Valabrega
    Citation: Journal of Ovarian Research 2019 12:17
  31. Successful pregnancy outcome in women with synchronous ovarian and endometrial cancers is very rare. We report successful pregnancy ... woman managed conservatively for synchronous endometrial and ovarian cancer.

    Authors: Vanita Suri, Ramandeep Bansal, Neelam Aggarwal, Pooja Sikka, Seema Chopra, Subhash Chandra Saha, Nalini Gupta and Bhavana Rai
    Citation: Journal of Ovarian Research 2023 16:63
  32. MMP-7 and TIMP-1 may play a role in the pathogenesis of cancer disease. In this study we investigated plasma ... ) in selected histological types of epithelial ovarian cancer patients as compared to control group...

    Authors: Grażyna Ewa Będkowska, Ewa Gacuta, Monika Zajkowska, Edyta Katarzyna Głażewska, Joanna Osada, Maciej Szmitkowski, Lech Chrostek, Milena Dąbrowska and Sławomir Ławicki
    Citation: Journal of Ovarian Research 2017 10:39
  33. Antibody resistance, not only de novo...but also acquired cases, usually exists and is related with lower survival rate and high risk of recurrence. Reversing the resistance often results in better clinical thera...

    Authors: Wei Wang, Yan Zhang, Ming Lv, Jiannan Feng, Hui Peng, Jing Geng, Zhou Lin, Tingting Zhou, Xinying Li, Beifen Shen, Yuanfang Ma and Chunxia Qiao
    Citation: Journal of Ovarian Research 2014 7:103
  34. High-grade serous carcinoma (HGSC) is the most common and aggressive subtype of epithelial ovarian cancer, characterized by gain-of-function TP53...mutations originating in the fallopian tube epithelium. Therapeu...

    Authors: Madison Pereira, Alice Glogova, Jacob Haagsma, Julia Stewart, Trevor G. Shepherd and Jim Petrik
    Citation: Journal of Ovarian Research 2023 16:218
  35. Hyaluronic acid is a prognostic factor in ovarian cancers. It is also a component of Hyaluronic ... surgery will relapse due to the persistence of cancer cells. This study’s objective was to...

    Authors: Laetitia Picaud, Benoît Thibault, Eliane Mery, Monia Ouali, Alejandra Martinez, Jean-Pierre Delord, Bettina Couderc and Gwenael Ferron
    Citation: Journal of Ovarian Research 2014 7:40
  36. Epithelial ovarian cancer (EOC) is a gynecological disease with...Wt1) genes in cancer, which may be related to the existence...Wt1 (+KTS) or Wt1 (−KTS) overexpression can significantly promote the proliferation ...

    Authors: Xiaomei Wang, Jingyu Zhao, Yixin Zhang, Yuxin Liu, Jinzheng Wang, Ruoxi Shi, Jinxiang Yuan and Kai Meng
    Citation: Journal of Ovarian Research 2023 16:46
  37. A new technique has successfully established the non-obese diabetic/severely combined immunodeficiency (NOD/SCID) mouse model of ovarian cancer. Under 4% chloral hydrate (0.1...d/H-2Dd...) were observed using a c...

    Authors: Hui Zhang, Xinping Gao, Yongan Yang, Weiming Wang, Jin Liu, Yijuan Liang, Hongli Wu, Jinjin Qin, Kun Pan, Yifeng Wang, Junrong Shi and Youju Ma
    Citation: Journal of Ovarian Research 2014 7:64
  38. The objective of this study was to evaluate the feasibility of fertility preservation in cancer patients by combined bilateral ovarian cortex cryopreservation...

    Authors: Marie-Madeleine Dolmans, Maria-Laura Marotta, Céline Pirard, Jacques Donnez and Olivier Donnez
    Citation: Journal of Ovarian Research 2014 7:80
  39. Ovarian mucinous carcinoma is a disease that requires unique treatment. But for a long time, guidelines for ovarian serous carcinoma have been used for the treatment of ovarian mucinous carcinoma. This study aime...

    Authors: Li Yang, Jinfen Yu, Shuang Zhang, Yisi Shan, Yajun Li, Liugang Xu, Jinhu Zhang and Jianya Zhang
    Citation: Journal of Ovarian Research 2022 15:26

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

Editor News

New Content ItemEditor-in-Chief Dr Ben Tsang has been recognised by the Canadian Parliament for significant contributions to science. Please join us in celebrating this amazing achievement.

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.